Fundraising FoxGoldman Sachs — 2024 Investments
12 investments dated 2024 · listed companies and verified rows first · show all
Securing the world's data
Palo Alto, US
Bipul Sinha(Founder)inArvind Nithrakashyap(Founder)inArvind Jain(Founder)inSoham Mazumdar(Founder)inKiran Choudary(Chief Financial Officer)inJesse Green(Chief Revenue Officer)in
Co-investors3Spoke CapitalAccess Ventures (New York)Adit Ventures Management, LlcAnicut CapitalBain Capital VenturesChamaeleon+24 more
Apex Group is an independent investment advisory firm specializing in alternatives and private markets, providing institutional investors with advisory services across asset classes including private equity, venture capital, hedge funds, and digital assets.
Data & InfrastructureEnterprise SoftwareFintechSaaSSector Agnostic
Peter Hughes(Founder)in
Co-investorsGenstarTA Associates
Canoe Intelligence provides AI-driven software and data infrastructure for alternative investment management, processing capital call notices, distribution notices, and capital account statements from institutional fund managers to deliver real-time visibility into capital flows across trillions in assets under administration.
AI & Machine LearningData & InfrastructureEnterprise SoftwareFintechSaaS
Jason Eiswerth(CEO)inNoel Calhoun(CTO)in
Co-investorsF-Prime CapitalInner Loop Capital
Digit Life offers life insurance products in India, including term life, group term life, and health-linked life plans sold to individuals and groups.
Cloud ComputingFintechInsurTechBengaluru, IN
Jasleen Kohli(Managing Director & Chief Executive Officer)inKamesh Goyal(Chairman)Ravi Khetan(Chief Financial Officer)Parimal Heda(Chief Investment Officer)Rajeev Singh(Chief Technical and Risk Officer)Rasika Kuber(Chief Compliance Officer)
Co-investorsPeak XV PartnersWellington ManagementSBI Mutual FundSequoia CapitalSteadview Capital
Digital Biology (Digit Bio) develops precision biologics and combination therapies for solid tumors, using its M×P (Molecules × Phenotypes) Platform that combines high-resolution imaging, next-generation sequencing, computation, and AI to map the spatial molecular organization of tumor tissues.
AI & Machine LearningBiotechDeep TechHealthtech
Co-investorsFifty YearsA91 PartnersHSBCMorgan StanleyPeak XV PartnersSteadview Capital
HUMAN is a cybersecurity company focused on detecting and stopping automated bot attacks and digital fraud.
AdTechAI & Machine LearningCybersecurityEnterprise SoftwareSaaSBrooklyn, US
Ashur Kalb(Executive Officer)Tamer Hassan(Founder)inMichael Tiffany(Founder)inDan Kaminsky(Founder)Ash Kalb(Founder)in
BoardSteven Fredrick(Director)
Co-investors11.2 CapitalCanaan PartnersDCVC (Data Collective)Evolution VC PartnersGrit Capital PartnersGrotech Ventures+10 more
Kontakt.io provides an AI-powered real-time location system and care operations platform for hospitals, combining Bluetooth LE devices, managed IoT infrastructure, and cloud analytics to optimize patient and staff safety, reduce length of stay, and streamline healthcare operations.
AI & Machine LearningHealthtechIoTSaaSNew York City, US
Tomasz Kolek(Executive Officer, Director)Szymon Niemczura(Executive Officer, Director)inPhilipp von Gilsa(CEO)inJohn Turekin
BoardJan Habermann(Director)inMaximilian Niederhofer(Director)
Co-investorsHeartcore CapitalCredo VenturesSunstone Capital
Simetrik offers a no-code enterprise SaaS platform for automating financial controls, serving finance operations and accounting teams.
AI & Machine LearningEnterprise SoftwareFintechSaaSBogotá, CO
Alejandro Casas(CEO)inSantiago Gomez(CFO/COO)inAlejandro Casas Caro(Founder)inAlejandro Casas Santiago Gomez(Founder)
Co-investorsAmador HoldingsCapria VenturesClocktower VenturesCometaFinTech CollectiveFJ Labs+20 more
TORL BioTherapeutics develops antibody-drug conjugates (ADCs) targeting Claudin 6 (CLDN6) for the treatment of solid tumors such as ovarian, lung, endometrial, and testicular cancers.
BiotechHealthtechCulver City, US
Dave LicatainAran Maree M.D.inMark Alles(Executive Officer, Director)Mark Attanasio(Director)David Licata(Executive Officer, Director)Neil O'Brien(Director)
Co-investorsOCV PartnersRA CapitalCowen Healthcare InvestmentsPerceptive Xontogeny VentureVertex Ventures HC
Transcendia manufactures and converts synthetic paper and film products for applications including backlit displays, point-of-purchase signage, retail graphics, menus, banners, tags, labels, and secure ID cards.
Advanced ManufacturingNew MaterialsPark Ridge, US
Scott Danielin
BoardCharles H. Gailliot(Executive Officer, Director)
Co-investorsIndustrial Opportunity Partners
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.